Northwestern Mutual Wealth Management’s Aclaris Therapeutics ACRS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.88K	Hold	500	–	–	﹤0.01%	3615
2025 Q4	$1.5K	Hold	500	–	–	﹤0.01%	3551
2025 Q3	$950	Hold	500	–	–	﹤0.01%	3556
2025 Q2	$710	Hold	500	–	–	﹤0.01%	3419
2025 Q1	$765	Hold	500	–	–	﹤0.01%	3324
2024 Q4	$1.24K	Hold	500	–	–	﹤0.01%	3264
2024 Q3	$575	Hold	500	–	–	﹤0.01%	3329
2024 Q2	$550	Hold	500	–	–	﹤0.01%	3278
2024 Q1	$620	Hold	500	–	–	﹤0.01%	3256
2023 Q4	$525	Hold	500	–	–	﹤0.01%	3270
2023 Q3	$3.42K	Hold	500	–	–	﹤0.01%	2844
2023 Q2	$5.18K	Hold	500	–	–	﹤0.01%	2770
2023 Q1	$4.04K	Hold	500	–	–	﹤0.01%	2805
2022 Q4	$7.88K	Hold	500	–	–	﹤0.01%	2584
2022 Q3	$8K	Hold	500	–	–	﹤0.01%	2513
2022 Q2	$7K	Hold	500	–	–	﹤0.01%	2612
2022 Q1	$9K	Hold	500	–	–	﹤0.01%	2558
2021 Q4	$7K	Hold	500	–	–	﹤0.01%	2665
2021 Q3	$9K	Hold	500	–	–	﹤0.01%	2487
2021 Q2	$9K	Hold	500	–	–	﹤0.01%	2451
2021 Q1	$13K	Hold	500	–	–	﹤0.01%	2201
2020 Q4	$3K	Hold	500	–	–	﹤0.01%	2442
2020 Q3	$1K	Hold	500	–	–	﹤0.01%	2414
2020 Q2	$1K	Hold	500	–	–	﹤0.01%	2263
2020 Q1	$1K	Buy	+500	New	+$681	﹤0.01%	2341

Other funds holding ACRS

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Northwestern Mutual Wealth Management's ACRS Position: Q1 2026 in Review

Northwestern Mutual Wealth Management held its Aclaris Therapeutics (ACRS) position steady in Q1 2026 at 500 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3615.

Northwestern Mutual Wealth Management first reported a position in ACRS in Q1 2020 and has held it in 25 quarters since. The position peaked at $13K in Q1 2021. 136 funds tracked by Wall St. Rank hold ACRS as of Q1 2026.

Northwestern Mutual Wealth Management held 500 shares of Aclaris Therapeutics worth $1.88K as of Q1 2026.
Northwestern Mutual Wealth Management left its Aclaris Therapeutics share count unchanged in Q1 2026.
Aclaris Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3615 holding.
Northwestern Mutual Wealth Management first reported a position in Aclaris Therapeutics in Q1 2020 and has held it in 25 quarters since.
Northwestern Mutual Wealth Management's Aclaris Therapeutics position peaked at $13K in Q1 2021.
136 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.